Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells
Top Cited Papers
Open Access
- 22 May 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 149 (2) , 353-363
- https://doi.org/10.1111/j.1365-2249.2007.03422.x
Abstract
The ability of mesenchymal stem cells (MSC) to suppress alloresponsiveness is poorly understood. Herein, an allogeneic mixed lymphocyte response was used as a model to investigate the mechanisms of MSC-mediated immunomodulation. Human MSC are demonstrated to express the immunosuppressive cytokines hepatocyte growth factor (HGF), interleukin (IL)-10 and transforming growth factor (TGF)-β1 at concentrations that suppress alloresponses in vitro. MSC also express cyclooxygenase 1 and 2 and produce prostaglandin E2 constitutively. Blocking studies with indomethacin confirmed that prostaglandins contribute to MSC-mediated allosuppression. The proinflammatory cytokine interferon (IFN)-γ did not ablate MSC inhibition of alloantigen-driven proliferation but up-regulated HGF and TGF-β1. IFN-γ also induced expression of indoleamine 2,3, dioxygenase (IDO), involved in tryptophan catabolism. Use of an antagonist, 1-methyl-L-tryptophan, restored alloresponsiveness and confirmed an IDO contribution to IFN-γ-induced immunomodulation by MSC. Addition of the tryptophan catabolite kynurenine to mixed lymphocyte reactions (MLR), blocked alloproliferation. These findings support a model where IDO exerts its effect through the local accumulation of tryptophan metabolites rather than through tryptophan depletion. Taken together, these data demonstrate that soluble factors, or products derived from MSC, modulate immune responses and suggest that MSC create an immunosuppressive microenvironment capable of modulating alloresponsiveness even in the presence of IFN-γ.Keywords
This publication has 53 references indexed in Scilit:
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2005
- Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathwayEuropean Journal of Immunology, 2005
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Mesenchymal stem cells: clinical applications and biological characterizationThe International Journal of Biochemistry & Cell Biology, 2004
- HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cellsPublished by Elsevier ,2003
- Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant womenJournal of Medical Virology, 2003
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationTransplantation, 2003
- Cognate interactions between helper T cells and B cellsImmunology Today, 1990
- Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxygenase cDNABiochemical and Biophysical Research Communications, 1990